Terapia diuretica nell’insufficienza cardiaca cronica: evidenze, esperienze, prospettive = Diuretic treatment in patients with chronic heart failure: evidences, experiences, and current perspectives [PDF]
Congestion is a fundamental clinical sign in patients with chronic heart failure (CHF). Diuretics are the mainstay treatment for congestion but, so far, no randomized trial has ever shown any beneficial effect of diuretics on mortality in patients with ...
Carubelli, Valentina +1 more
core +1 more source
Objective: To investigate the efficacy of metoprolol combined with torasemide in elderly patients with degenerative valvular heart disease (DVHD) and heart failure and its influence on N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations.
K. Ren +4 more
semanticscholar +1 more source
Purpose: We aimed to comprehensively evaluate the curative effect of torasemide, tolvaptan, furosemide and azosemide on patients with heart failure. Methods: Relevant studies were retrieved by searching the electronic databases until May 2018.
Xingsheng Zhao, Yu Ren, Hui Li, Xi Liu
doaj +1 more source
Incomplete right bundle branch block associated with coagulation disturbance in mitral valvular disease in a dog – case report [PDF]
An incomplete right bundle branch block (RBBB) associated with coagulation disturbance in mitral valvular disease was diagnosed in a five-year-old female Dachshund.
Sindhu K. Rajan +6 more
doaj +1 more source
Functional modulation of the transient outward current Ito by KCNE beta-subunits and regional distribution in human non-failing and failing hearts [PDF]
Objectives: The function of Kv4.3 (KCND3) channels, which underlie the transient outward current I,, in human heart, can be modulated by several accessory subunits such as KChIP2 and KCNE1-KCNE5.
Banse, U. +8 more
core +1 more source
Aim. To study effect of diuretic therapy with furosemide and torasemide on heart rate variability (HRV) and frequency of ventriclar rhythm disorders in patients with chronic heart failure (CHF) complicating ischemic heart disease (IHD).Material and ...
H. H. Shugushev, A. A. Gaeva
doaj +1 more source
Genomics and precision medicine for clinicians and scientists in hypertension [PDF]
No abstract ...
Delles, Christian +2 more
core +1 more source
Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney. [PDF]
BackgroundExcess body burden of uric acid promotes gout. Diminished renal clearance of uric acid causes hyperuricemia in most patients with gout, and the renal urate transporter (URAT)1 is important for regulation of serum uric acid (sUA) levels.
Girardet, Jean-Luc +12 more
core +2 more sources
Overview of Diuretic Strategies in Edematous States [PDF]
Considering potential physiologic causes of volume overload in clinical practice, such as heart failure, renal failure, nephrotic syndrome, or portal hypertension, may yield insight into directing therapy beyond switching from oral to intravenous ...
Mahajan, MD, Kedar
core +4 more sources

